Speaker illustration

Professor Thibaud Damy

University Hospital Henri Mondor, Creteil (France)

Member of:

European Society of Cardiology
Heart Failure Association

Pr Thibaud Damy’s field of interest are Heart failure and Cardiac Amyloidosis, through to their diagnosis and treatment. His particular current interests are developpement of HF Nurses in France and improving CA diagnosing and treatment at the national level. He is working at the Hospital Henri Mondor, at Paris East Creteil University (UPEC) and at INSERM U955 (Clinical EPidemiology in Aging (CEPIA). He is leading the Referral Center for Cardiac Amyloidosis from the Cardiogen French Network /ERN. He and his team created a wide educational programme to improve the knowledge and quality of life of the patients (Amylo-PEP). He is leading the French National Amyloidosis Network gathering and the Healthcare European Amyloidosis Registry that has included around 4500 patients with amyloidoisis. He is a co-author of around 240 articles (>100 on amyloidosis). He is coordinating several websites : www.reseau-amylose.org, www.vaincrelinsuffisancecardiaque.org

Myocardial disease - clinical 3

Event: Heart Failure 2024

Topic: Clinical

Session type: Moderated ePosters

Thumbnail

How to manage cardiac amyloidosis

Event: Heart Failure 2024

Topic: Myocardial Disease

Session type: HowTo

Thumbnail

Evaluation of prognosis in cardiomyopathies

Event: Heart Failure 2024

Topic: Myocardial Disease

Session type: Rapid Fire Abstracts

Thumbnail

Challenges in ATTR Amyloidosis: an expert debate

Event: Heart Failure 2024

Topic: Cardiac Amyloidosis

Session type: Satellite Symposium

Thumbnail

Ask the Trialists from Hot Line 5

Event: ESC Congress 2023

Topic: European Society of Cardiology

Session type: Ask the Trialists

Thumbnail

Chronic heart failure - Amyloidosis

Event: ESC Congress 2022

Topic: Chronic Heart Failure

Session type: Moderated ePosters

Thumbnail

Myocardial disease: clinical characterization and therapeutical progress

Event: Heart Failure 2022

Topic: Myocardial Disease

Session type: Moderated Posters

Thumbnail

New targets to enhance survival and outcomes in hATTR amyloidosis

Event: Heart Failure 2022

Topic: Clinical

Session type: Satellite Symposium

Thumbnail

Faces and Cases: Improving the Management of Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Event: ESC Congress 2020

Topic: Treatment

Session type: Industry Live

Thumbnail

Looking to the future of identifying transthyretin amyloid cardiomyopathy

Event: ESC Congress 2019

Topic: Chronic Heart Failure

Session type: Satellite Symposium

Thumbnail